Illumina (ILMN) Competitors $76.51 -1.09 (-1.40%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$77.22 +0.71 (+0.93%) As of 05/1/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ILMN vs. A, MTD, WAT, TECH, BIO, BRKR, CRL, PACB, HBIO, and TMOShould you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Charles River Laboratories International (CRL), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), and Thermo Fisher Scientific (TMO). These companies are all part of the "life sciences tools & services" industry. Illumina vs. Agilent Technologies Mettler-Toledo International Waters Bio-Techne Bio-Rad Laboratories Bruker Charles River Laboratories International Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Illumina (NASDAQ:ILMN) and Agilent Technologies (NYSE:A) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, community ranking, valuation, earnings, risk and dividends. Does the media favor ILMN or A? In the previous week, Agilent Technologies had 5 more articles in the media than Illumina. MarketBeat recorded 23 mentions for Agilent Technologies and 18 mentions for Illumina. Agilent Technologies' average media sentiment score of 1.22 beat Illumina's score of 1.16 indicating that Agilent Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 12 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Agilent Technologies 18 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Which has stronger valuation and earnings, ILMN or A? Agilent Technologies has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Agilent Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIllumina$4.37B2.77-$1.22B-$7.68-9.96Agilent Technologies$6.51B4.66$1.29B$4.3524.47 Is ILMN or A more profitable? Agilent Technologies has a net margin of 19.27% compared to Illumina's net margin of -27.95%. Agilent Technologies' return on equity of 25.56% beat Illumina's return on equity.Company Net Margins Return on Equity Return on Assets Illumina-27.95% 13.37% 5.49% Agilent Technologies 19.27%25.56%13.47% Which has more volatility & risk, ILMN or A? Illumina has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Comparatively, Agilent Technologies has a beta of 1.19, meaning that its stock price is 19% more volatile than the S&P 500. Do analysts prefer ILMN or A? Illumina currently has a consensus price target of $137.55, indicating a potential upside of 79.78%. Agilent Technologies has a consensus price target of $143.00, indicating a potential upside of 34.32%. Given Illumina's stronger consensus rating and higher probable upside, analysts plainly believe Illumina is more favorable than Agilent Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Illumina 1 Sell rating(s) 10 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.48Agilent Technologies 0 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.46 Do insiders & institutionals have more ownership in ILMN or A? 89.4% of Illumina shares are held by institutional investors. 0.2% of Illumina shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor ILMN or A? Illumina received 246 more outperform votes than Agilent Technologies when rated by MarketBeat users. However, 71.01% of users gave Agilent Technologies an outperform vote while only 65.24% of users gave Illumina an outperform vote. CompanyUnderperformOutperformIlluminaOutperform Votes111365.24% Underperform Votes59334.76% Agilent TechnologiesOutperform Votes86771.01% Underperform Votes35428.99% SummaryAgilent Technologies beats Illumina on 11 of the 19 factors compared between the two stocks. Get Illumina News Delivered to You Automatically Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ILMN vs. The Competition Export to ExcelMetricIlluminaAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.11B$4.12B$5.47B$7.92BDividend YieldN/A0.57%5.11%4.22%P/E Ratio-9.9626.9722.5118.54Price / Sales2.774.24397.62103.35Price / Cash20.7236.1538.1834.62Price / Book5.111.666.734.25Net Income-$1.22B-$83.57M$3.22B$248.18M7 Day Performance-1.42%-4.06%1.58%1.25%1 Month Performance-2.40%-0.38%4.05%3.76%1 Year Performance-38.63%-33.76%15.75%5.28% Illumina Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ILMNIllumina4.6924 of 5 stars$76.51-1.4%$137.55+79.8%-38.6%$12.11B$4.37B-9.9611,500Upcoming EarningsAnalyst ForecastPositive NewsAAgilent Technologies4.7278 of 5 stars$106.76+0.4%$143.00+34.0%-23.2%$30.42B$6.51B24.5317,900Positive NewsMTDMettler-Toledo International3.7211 of 5 stars$1,062.89+0.1%$1,304.25+22.7%-15.7%$22.12B$3.87B26.1918,000Earnings ReportShort Interest ↑Positive NewsWATWaters3.9708 of 5 stars$339.84+0.6%$392.13+15.4%+8.1%$20.22B$2.96B31.748,200Upcoming EarningsTECHBio-Techne4.8731 of 5 stars$50.36+0.2%$81.14+61.1%-32.4%$7.96B$1.20B50.873,000BIOBio-Rad Laboratories4.4017 of 5 stars$239.04-1.5%$380.20+59.1%-12.2%$6.70B$2.57B-3.688,200Earnings ReportShort Interest ↑News CoveragePositive NewsBRKRBruker4.983 of 5 stars$39.49+1.1%$65.00+64.6%-50.2%$5.98B$3.37B51.958,520Upcoming EarningsShort Interest ↓Positive NewsCRLCharles River Laboratories International4.8185 of 5 stars$115.11+0.4%$182.00+58.1%-49.8%$5.64B$4.05B765.8821,400Upcoming EarningsPACBPacific Biosciences of California3.1663 of 5 stars$1.13+3.2%$2.45+117.8%-34.3%$334.49M$154.01M-0.68730Upcoming EarningsNews CoverageHBIOHarvard Bioscience3.941 of 5 stars$0.38+1.1%$4.50+1,081.1%-91.1%$16.85M$94.14M-1.15490Upcoming EarningsAnalyst ForecastGap UpTMOThermo Fisher Scientific4.8533 of 5 stars$420.24-0.9%$616.95+46.8%-27.0%$158.48B$42.90B25.40130,000Analyst ForecastInsider TradeShort Interest ↑ Related Companies and Tools Related Companies Agilent Technologies Alternatives Mettler-Toledo International Alternatives Waters Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Charles River Laboratories International Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ILMN) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Illumina, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Illumina With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
